The U.S. is preparing to announce sweeping tariffs on pharmaceutical imports within the next two months, according to ...

Discrepancy between individuals’ and governments’ compensations highlights a sense of injustice felt by people directly ...

Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.

Piper Sandler analysts highlighted their top picks for biotechnology for investors amid the rollercoaster seen in the equity ...

The number of employees laid off dropped year over year during the first quarter. BioSpace recaps the five largest layoffs, ...

Despite challenges from market uncertainty and the potential impacts of tariffs, executives from Bay Area startups Abridge, ...

A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...

The market turbulence unleashed by President Donald Trump’s tariff policies will likely evaporate the trickle of biotech IPOs ...

The pair examine industry trends, company closures, developments in the cell and gene space—and the reductions in force ...

Find out what makes Basel's biotech hub so successful, as it has cemented its place as one of Europe's brightest life ...

Photo: Alamy Novartis announced on Thursday that it will invest $23 billion in the U.S. over the next five years. The ...

On the profitability front, we expect the EBIT margin to expand to 4.0% by fiscal 2029 from 3.8% in fiscal 2024. This is based on volume-driven operational efficiencies, increasing capacity ...